Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascent Pediatrics was a specialty pharmaceutical company dedicated to the development and commercialization of prescription products for the pediatric market. Founded in 1989 and based in Wilmington, Massachusetts, the company focused on improving treatments for common pediatric conditions such as asthma, infections, and allergies. Its flagship product was Orapred (prednisolone sodium phosphate), a liquid corticosteroid designed for better palatability and compliance in children. Ascent was acquired by Medicis Pharmaceutical Corporation in 2001 and subsequently sold to BioMarin Pharmaceutical in 2004 to serve as the foundation for BioMarin's commercial pediatric infrastructure. The company's portfolio also included Primsol for ear infections and various respiratory treatments. It was recognized for its expertise in pediatric drug delivery and taste-masking technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ascent Pediatrics.